US$ 24.01
american diabetes association history of pancreatitis glp-1 receptor agonist Understanding GLP-1 receptor agonists and their impact on drug discovery american diabetes association pancreatitis history
Description
References Hunter DJ, Bierma-Zeinstra S
Foundayo can be prescribed through telehealth platforms that offer weight care services, allowing you to consult with clinicians virtually and receive a prescription if clinically appropriate

Moreover, a retrospective real-world study shows that both GLP1-RA and SGLT-2 inhibitors reduce the 10-year risk for cardiovascular disease in patients with T2D in primary cardiovascular prevention [17], although SGLT-2 inhibitors seem to have a greater cardioprotective benefit compared to GLP-1RA when used for secondary prevention among adults with T2D [18]

The results of a meta-analysis indicate that GLP-1RAs can reduce major adverse cardiovascular events (MACE) such as cardiovascular death, stroke, or myocardial infarction, as well as hospital admissions for heart failure and all-cause mortality, in patients with T2D [44]

They can improve weight loss and health and reduce mortality

At 26 weeks after treatment, the weight loss was -2.29 0.24 kg for 1.5 mg DUL, -1.36 0.24 kg for 0.75 mg DUL, and -2.22 0.24 kg for metformin (110)
